Following the ESC algorithm, the initial focus is on obtaining the patients medical history and conducting a clinical examination, followed by an electrocardiogram (ECG)
Kolarikova M, Hosikova B, Dilenko H, BartonTomankova K, Valkova L, Bajgar R, et al
Tirzepatide is ideal for adults who need a more aggressive, physician-guided approach to weight loss
For patients co-infected with HIV, Miltefosine has demonstrated potential in Ethiopian trials, though the rise of drug resistance in endemic regions remains a concern (Ritmeijer et al., 2006)
Step 5: Follow-up care and dose adjustments Tirzepatide is started at 2.5 mg/week for four weeks, then increased in 2.5 mg increments every four weeks up to 15 mg/week based on tolerability and response